Pituitary

Article	Citations
A Pituitary Society update to acromegaly management guidelines	184
COVID-19 and the pituitary	76
Postoperative diabetes insipidus: how to define and grade this complication?	54
Pituitary apoplexy associated with acute COVID-19 infection and pregnancy	50
Isolated ACTH deficiency induced by cancer immunotherapy: a systematic review	46
Descriptive epidemiology of craniopharyngiomas in the United States	39
Skull base repair following endonasal pituitary and skull base tumour resection: a systematic review	32
Clinical, biological, radiological, and pathological comparison of sparsely and densely granulated somatotroph adenomas: a single center experience from a cohort of 131 patients with acromegaly	31
Pituitary society expert Delphi consensus: operative workflow in endoscopic transsphenoidal pituitary adenoma resection	29
Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study	28
Glucocorticoid use in patients with adrenal insufficiency following administration of the COVID-19 vaccine: a pituitary society statement	27
Mice with gene alterations in the GH and IGF family	26
Consensus on criteria for acromegaly diagnosis and remission	25
Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome	24
Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States	24
Pre-operative serum inflammation-based scores in patients with pituitary adenomas	22
Diabetes insipidus after endoscopic transsphenoidal surgery: multicenter experience and development of the SALT score	21
Selective resection of cushing microadenoma guided by preoperative hybrid 18-fluoroethyl-L-tyrosine and 11-C-methionine PET/MRI	20
Impact of intraoperative magnetic resonance imaging on gross total resection, extent of resection, and residual tumor volume in pituitary surgery: systematic review and meta-analysis	19
Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing’s syndrome	18
Diagnostic value of Knosp grade and modified Knosp grade for cavernous sinus invasion in pituitary adenomas: a systematic review and meta‐analysis	18
Machine learning in predicting early remission in patients after surgical treatment of acromegaly: a multicenter study	18
Cephalocaudal tumor diameter is a predictor of diabetes insipidus after endoscopic transsphenoidal surgery for non-functioning pituitary adenoma	18
Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors—a review of research and clinical practice	17
Differences between immunotherapy-induced and primary hypophysitis—a multicenter retrospective study	17

Cardiovascular health and mortality in Cushing’s disease	17
Opioids and pituitary function: expert opinion	17
Corticotroph tumor progression during long-term therapy with osilodrostat in a patient with persistent Cushing’s disease	16
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience	16
Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression	16
Virtual magnetic resonance elastography has the feasibility to evaluate preoperative pituitary adenoma consistency	16
Incidence, mortality, and cardiovascular diseases in pituitary adenoma in Korea: a nationwide population-based study	16
Real-world experience with pasireotide-LAR in resistant acromegaly: a single center 1-year observation	16
Neural network modeling for prediction of recurrence, progression, and hormonal non-remission in patients following resection of functional pituitary adenomas	16
Cushing’s disease: adrenal steroidogenesis inhibitors	16
The direct and indirect impact of the COVID-19 pandemic on the care of patients with pituitary disease: a cross sectional study	15
Levoketoconazole in the treatment of patients with endogenous Cushing’s syndrome: a double-blind, placebo-controlled, randomized withdrawal study (LOGICS)	15
The microenvironment of pituitary adenomas: biological, clinical and therapeutical implications	15
The NETting of pituitary adenoma: a gland illusion	15
Complication avoidance protocols in endoscopic pituitary adenoma surgery: a retrospective cohort study in 514 patients	15
Epidemiology of common and uncommon adult pituitary tumors in the U.S. according to the 2017 World Health Organization classification	15
Clinical profiles of silent corticotroph adenomas compared with silent gonadotroph adenomas after adopting the 2017 WHO pituitary classification system	15
Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers	15
Effects of adult growth hormone deficiency and replacement therapy on the cardiometabolic risk profile	14
Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis	14
Pituitary adenomas in older adults (≥ 65 years): 90-day outcomes and readmissions: a 10-year endoscopic endonasal surgical experience	14
Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteers	14
HOMA-IR in acromegaly: a systematic review and meta-analysis	14
Prognostic value of nadir GH levels for long-term biochemical remission or recurrence in surgically treated acromegaly	14
Extending lifespan by modulating the growth hormone/insulin-like growth factor-1 axis: coming of age	14
Surgery is a safe, effective first-line treatment modality for noninvasive prolactinomas	14
Treatment of Cushing’s syndrome with osilodrostat: practical applications of recent studies with case examples	14
Modern imaging in Cushing’s disease	14
Long-term efficacy and safety of osilodrostat in Cushing’s disease: final results from a Phase II study with an optional extension phase (LINC 2)	13
Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results	13
Endocrine disorders after primary gamma knife radiosurgery for pituitary adenomas: A systematic review and meta-analysis	13
Normative data for pituitary size and volume in the general population between 50 and 66 years	13
Gut microbiota in patients with newly diagnosed acromegaly: a pilot cross-sectional study	13
Prolactin immunoassay: does the high-dose hook effect still exist?	13
Quality of life impairment after a diagnosis of Cushing’s syndrome	12
Glucocorticoid receptor blockers	12
Novel approaches to bone comorbidity in Cushing’s disease: an update	12
Implementation of functional imaging using 11C-methionine PET-CT co-registered with MRI for advanced surgical planning and decision making in prolactinoma surgery	12
AIP variant causing familial prolactinoma	12
Targeted therapies in the medical management of craniopharyngioma	12
Predictive factors of postoperative diabetes insipidus in 333 patients undergoing transsphenoidal surgery for non-functioning pituitary adenoma	12
The sellar barrier on preoperative imaging predicts intraoperative cerebrospinal fluid leak: a prospective multicenter cohort study	12
Frailty does not preclude surgical success after endoscopic transsphenoidal surgery for pituitary adenomas	11
11C-methionine PET aids localization of microprolactinomas in patients with intolerance or resistance to dopamine agonist therapy	11
Genetics of Cushing’s disease: from the lab to clinical practice	11
Effect of long-term growth hormone replacement on glucose metabolism in adults with growth hormone deficiency: a systematic review and meta-analysis	11
Prevalence of Nelson’s syndrome after bilateral adrenalectomy in patients with cushing’s disease: a systematic review and meta-analysis	10
Comparison between extended transsphenoidal and transcranial surgery for craniopharyngioma: focus on hypothalamic function and obesity	10
Surgical outcomes of medically failed prolactinomas: a systematic review and meta-analysis	10
Pituitary stalk interruption syndrome: phenotype, predictors, and pathophysiology of perinatal events	10

HLA analysis of immune checkpoint inhibitor-induced and idiopathic isolated ACTH deficiency	9
Late Night Salivary Cortisol in the diagnosis of neoplastic hypercortisolism (including cyclic Cushing’s syndrome)	9
Genetic spectrum and predictors of mutations in four known genes in Asian Indian patients with growth hormone deficiency and orthotopic posterior pituitary: an emphasis on regional genetic diversity	9
How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing)	9
Rathke’s cleft cyst infections and pituitary abscesses: case series and review of the literature	9
Typing of inflammatory lesions of the pituitary	9
Professor Rathke’s gift to neurosurgery: the cyst, its diagnosis, surgical management, and outcomes	9
Cystic appearance on magnetic resonance imaging in bihormonal growth hormone and prolactin tumors in acromegaly	9
The epidemiology and management patterns of pediatric pituitary tumors in the United States	9
Prevalence of clinical signs, symptoms and comorbidities at diagnosis of acromegaly: a systematic review in accordance with PRISMA guidelines	9
Anastrozole as add-on therapy for cabergoline-resistant prolactin-secreting pituitary adenomas: real-life experience in male patients	9
Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas	9
Refractory nonfunctioning pituitary adenomas	8
Serum copeptin levels at day two after pituitary surgery and ratio to baseline predict postoperative central diabetes insipidus	8
Increased risk of preneoplastic colonic lesions and colorectal carcinoma in acromegaly: multicenter case–control study	8
Machine learning as a clinical decision support tool for patients with acromegaly	8
Proportion and predictors of Hypogonadism Recovery in Men with Macroprolactinomas treated with dopamine agonists	8
A study on clinical outcomes of Rathke’s cleft cyst in patients managed conservatively	8
Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER	8
Management of prolactinomas in children and adolescents; which factors define the response to treatment?	8
Diagnosis and treatment outcomes of Cushing’s disease during pregnancy	8
Radiological evolution of autograft fat used for skull base reconstruction after transsphenoidal surgery for pituitary adenomas	8
Effects of oral macimorelin on copeptin and anterior pituitary hormones in healthy volunteers	8
Efficacy of temozolomide combined with capecitabine (CAPTEM) on refractory prolactinomas as assessed using an ex vivo 3D spheroid assay	8
Clinical and radiographic assessment of peripheral joints in controlled acromegaly	8
Outcomes of pituitary apoplexy: a comparison of microadenomas and macroadenomas	8
Treatment and prognostic factors of pituicytoma: a single-center experience and comprehensive literature review	8
How to manage intolerance to dopamine agonist in patients with prolactinoma	7
Integrated multi-omics profiling of nonfunctioning pituitary adenomas	7
Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment	7
Biochemical testing to differentiate Cushing’s disease from ectopic ACTH syndrome	7
The role of endoscopic endonasal surgery in the management of prolactinomas based on their invasiveness into the cavernous sinus	7
Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience	7
Prevalence of coronary calcium deposits in Sheehan’s syndrome patients on long term replacement treatment	7
Reported outcomes in transsphenoidal surgery for pituitary adenomas: a systematic review	7
Long-term hepatic and cardiac health in patients diagnosed with Sheehan’s syndrome	7
Growth hormone alters gross anatomy and morphology of the small and large intestines in age- and sex-dependent manners	7
Surgical strategies in the treatment of MR-negative Cushing’s Disease: a systematic review and treatment algorithm	7
Evaluation of acromegaly treatment direct costs with respect to biochemical control and follow-up length	7
Refractory lactotroph adenomas	7
Cushing’s disease: risk of recurrence following trans-sphenoidal surgery, timing and methods for evaluation	7
A systematic literature review to evaluate extended dosing intervals in the pharmacological management of acromegaly	7
Pituitary acting drugs: cabergoline and pasireotide	7
Usefulness of a clinicopathological classification in predicting treatment-related outcomes and multimodal therapeutic approaches in pituitary adenoma patients: retrospective analysis on a Portuguese	6
Effectiveness of the intraoperative magnetic resonance imaging during endoscopic endonasal approach for acromegaly	6
Responsiveness to DDAVP in Cushing’s disease is associated with USP8 mutations through enhancing AVPR1B promoter activity	6
Identification of mutant K-RAS in pituitary macroadenoma	6
Pituitary metastases from neuroendocrine neoplasms: case report and narrative review	6
Characteristics and overall survival in pediatric versus adult pituitary adenoma: a National Cancer Database analysis	6
Functioning gonadotroph adenomas in premenopausal women: clinical and molecular characterization and review of the literature	6
Hypopituitarism and pregnancy: clinical characteristics, management and pregnancy outcome	6
Genetics, clinical features and outcomes of non-syndromic pituitary gigantism: experience of a single center from Sao Paulo, Brazil	6
Differences in clinical, hormonal, and radiological presentation and in surgical outcomes in patients presenting with and without pituitary apoplexy. A multicenter study of 245 cases	6
Psychosocial effects and clinic reflections of the COVID-19 outbreak in patients with acromegaly and Cushing’s disease	6
Chiasmal herniation following treatment of pituitary macroadenoma	6
Treatment of recurrent and persistent Cushing’s disease after first transsphenoidal surgery: lessons learned from an international meta-analysis	6
A prospective study on the efficacy of oral estrogen in female patients with acromegaly	6
A comparison of macular ganglion cell and retinal nerve fibre layer optical coherence tomographic parameters as predictors of visual outcomes of surgery for pituitary tumours	6
The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults	6
Preoperative differentiation of hypophysitis and pituitary adenomas using a novel clinicoradiologic scoring system	6
Treatment of non-functioning pituitary adenoma with cabergoline: a systematic review and meta-analysis	6
Vasculometabolic effects in patients with congenital growth hormone deficiency with and without GH replacement therapy during adulthood	6
Pituitary tumor centers of excellence for Cushing’s disease	6
Predicting hypogonadotropic hypogonadism persistence in male macroprolactinoma	6
Vascular anomalies in patients with growth hormone-secreting pituitary adenomas: illustrative case report and systematic review of the literature	6
Acromegaly and pregnancy: a systematic review and meta-analysis	6
Hypercoagulability in Cushing’s syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols	6
Role of biological effective dose for prediction of endocrine remission in acromegaly patients treated with stereotactic radiosurgery	6
Management of sellar and parasellar tumors becoming symptomatic during pregnancy: a practical algorithm based on multi-center experience and systematic literature review	5
Long-term cardiometabolic outcome in patients with pituitary adenoma diagnosed in chilhood and adolescence	5
Risk factors for tumor recurrence and progression of spindle cell oncocytoma of the pituitary gland: a systematic review and pooled analysis	5
Long-term safety of gamma knife radiosurgery (SRS) for acromegaly	5
Transcriptome profiling of insulin sensitive tissues from GH deficient mice following GH treatment	5
POU1F1 mutations in combined pituitary hormone deficiency: differing spectrum of mutations in a Western-Indian cohort and systematic analysis of world literature	5
Exploring the role of the tumor microenvironment in refractory pituitary tumor pathogenesis	5
Characterization of the ability of a, second-generation SST-DA chimeric molecule, TBR-065, to suppress GH secretion from human GH-secreting adenoma cells	5
Giant prolactinoma in children and adolescents: a single-center experience and systematic review	5
Pituitary surgery in Cushing’s disease: first line treatment and role of reoperation	5
Pituitary apoplexy and panhypopituitarism following acute leptospirosis	5
Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours	5

Quality of life after long-term biochemical control of acromegaly	5
Healthcare utilization and costs among prolactinoma patients: a cross-sectional study and analysis of determinants	5
Acromegaly is associated with a distinct oral and gut microbiota	5
Increased oxytocin release precedes hyponatremia after pituitary surgery	5
Prior testosterone replacement therapy may impact spermatogenic response to combined gonadotropin therapy in severe congenital hypogonadotropic hypogonadism	5
Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency	5
Impact of patient-reported nasal symptoms on quality of life after endoscopic pituitary surgery: a prospective cohort study	4
Pituitary metastases: a case series and scoping review	4
The treatment of aggressive prolactinomas with everolimus	4
Machine learning models predict delayed hyponatremia post-transsphenoidal surgery using clinically available features	4
Changing presentation of acromegaly in half a century: a single-center experience	4
Surgical outcomes and quality of life in Rathke’s cleft cysts undergoing endoscopic transsphenoidal resection: a multicentre study and systematic review of the literature	4
Familial neurohypophyseal diabetes insipidus: clinical, genetic and functional studies of novel mutations in the arginine vasopressin gene	4
Refractory somatotroph adenomas	4
Predicting tumor consistency and extent of resection in non-functioning pituitary tumors	4
Double adenomas of the pituitary reveal distinct lineage markers, copy number alterations, and epigenetic profiles	4
Thyrotropin-secreting pituitary adenomas induce left atrial enlargement with subclinical atrial fibrillation: an echocardiographic study	4
The role of stereotactic radiosurgery in the multidisciplinary management of pituitary metastases	4
Psychological well-being and illness perceptions in patients with hypopituitarism	4
Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE)	4
Deficiency of WFS1 leads to the impairment of AVP secretion under dehydration in male mice	4
Surgically treated acromegaly patients have a similar quality of life whether controlled by surgery or requiring additional medical therapy (QuaLAT Study)	4
Venous thromboembolism chemical prophylaxis after endoscopic trans-sphenoidal pituitary surgery	4
Discrimination between non-functioning pituitary adenomas and hypophysitis using machine learning methods based on magnetic resonance imaging‑derived texture features	4
Growth hormone secreting pituitary adenomas show distinct extrasellar extension patterns compared to nonfunctional pituitary adenomas	4
Safety of endoscopic endonasal biopsy for the pituitary stalk-hypothalamic lesions	4
Role of Radiation in the treatment of Cushing Disease	4
Predictive value of macular ganglion cell-inner plexiform layer thickness in visual field defect of pituitary adenoma patients: a case-control study	4
Fully endoscopic endonasal approach for the treatment of intrasellar arachnoid cysts	3
The diagnosis and prevalence of hypoprolactinemia in patients with panhypopituitarism and the effects on depression and sexual functions	3
Evaluating the burden of endogenous Cushing’s syndrome using a web-based questionnaire and validated patient-reported outcome measures	3
An Infundibular Unidentified Object (IUO): a new pituitary stalk marker?	3
GnRH agonist-associated pituitary apoplexy: a case series and review of the literature	3
Cushing’s disease: role of bilateral adrenalectomy	3
Internal carotid artery stenosis and risk of cerebrovascular ischemia following stereotactic radiosurgery for recurrent or residual pituitary adenomas	3
Contemporary radiotherapy and radiosurgery techniques for refractory pituitary adenomas	3
Chiasmapexy for secondary empty sella syndrome: diagnostic and therapeutic considerations	3
Co-expression of intermediate filaments glial fibrillary acidic protein and cytokeratin in pituitary adenoma	3
Glucose metabolism, gut-brain hormones, and acromegaly treatment: an explorative single centre descriptive analysis	3
Overnight 1 mg dexamethasone suppression test and 24 h urine free cortisol—accuracy and pitfalls when screening for Cushing’s syndrome	3
Pituitary apoplexy score, toward standardized decision-making: a descriptive study	3
The impact of facility type and volume on treatment and overall survival in craniopharyngioma	3
Mental health disorders in newly diagnosed non-functional pitutary adenoma under initial observation: an observational cohort study using the nationwide MarketScan database	3
Clinico-radiological correlation of pituitary stalk interruption syndrome in children with growth hormone deficiency	3
Regional genotypic variations in normosmic congenital hypogonadotropic hypogonadism: our experience and systematic review	3
Antiplatelet and anticoagulation therapy and the risk of pituitary apoplexy in pituitary adenoma patients	3
The role of the dentist and orthodontist in recognizing oro-facial manifestations of acromegaly: a questionnaire-based study	3
Endoscopic endonasal marsupialization of rathke cleft cysts: clinical outcomes and risk factors analysis of visual impairment, pituitary dysfunction, and CSF leak	3
Patient-reported outcomes in refractory hormone-producing pituitary adenomas: an unmet need	3
Historical and future trends in emergency pituitary referrals: a machine learning analysis	3
Impact of histopathological classification of non-functioning adenomas on long term outcomes: comparison of the 2004 and 2017 WHO classifications	3
Post-operative surveillance for somatotroph, lactotroph and non-functional pituitary adenomas after curative resection: a systematic review	3